Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liting Yu

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of the American Chemical Society|May 21, 2026
Heteroatom-Engineered Covalent Organic Frameworks Break the CO<sub>2</sub> Separation Trade-Off in Mixed Matrix MembranesTsukasa Irie, Liting Yu, Sourav Ghosh, et al.
Journal of Nanobiotechnology|September 9, 2024
Rationally designed catalytic nanoplatform for enhanced chemoimmunotherapy via deploying endogenous plus exogenous copper and remodeling tumor microenvironmentDaxi Sun, Liting Yu, Gang Wang, et al.
Angewandte Chemie (International Ed. in English)|May 24, 2024
In Situ Transformation of an Amorphous Supramolecular Coating to a Hydrogen-Bonded Organic Framework Membrane to Trigger Selective Gas PermeationCaiyan Zhang, Zhikun Wang, Lu Qiao, et al.
RSC Advances|January 22, 2024
Novel porphyrin derivative containing cations as new photodynamic antimicrobial agent with high efficiencyJiajing Zhang, Xiaoqian Yuan, Hongsen Li, et al.
International Journal of Molecular Medicine|July 3, 2010
Trans-Zeatin attenuates ultraviolet induced down-regulation of aquaporin-3 in cultured human skin keratinocytesChao Ji, Yanli Yang, Bo Yang, et al.
Breast Cancer Research and Treatment|June 4, 2024
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancerWenning Shi, Cong Xu, Ping Lei, et al.
Biochemical and Biophysical Research Communications|September 26, 2025
PTPN2 acts as a tumor suppressor and therapeutic target in ovarian cancerXiaoli Sun, Wenkai Zhang, Hongmei Wang, et al.
British Journal of Haematology|March 3, 2024
High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic studyXiaoxiao Chen, Jing Li, Liting Yu, et al.
International Journal of Clinical Pharmacy|August 26, 2025
Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patientsHongya Ou, Zijan Tan, Anle Shen, et al.
Medical Oncology (Northwood, London, England)|January 4, 2024
Exploring the role of PRDX4 in the development of uterine corpus endometrial carcinomaPing Lei, Liting Yu, Xiaoli Sun, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of the American Chemical Society|May 21, 2026
Heteroatom-Engineered Covalent Organic Frameworks Break the CO<sub>2</sub> Separation Trade-Off in Mixed Matrix MembranesTsukasa Irie, Liting Yu, Sourav Ghosh, et al.
Journal of Nanobiotechnology|September 9, 2024
Rationally designed catalytic nanoplatform for enhanced chemoimmunotherapy via deploying endogenous plus exogenous copper and remodeling tumor microenvironmentDaxi Sun, Liting Yu, Gang Wang, et al.
Angewandte Chemie (International Ed. in English)|May 24, 2024
In Situ Transformation of an Amorphous Supramolecular Coating to a Hydrogen-Bonded Organic Framework Membrane to Trigger Selective Gas PermeationCaiyan Zhang, Zhikun Wang, Lu Qiao, et al.
RSC Advances|January 22, 2024
Novel porphyrin derivative containing cations as new photodynamic antimicrobial agent with high efficiencyJiajing Zhang, Xiaoqian Yuan, Hongsen Li, et al.
International Journal of Molecular Medicine|July 3, 2010
Trans-Zeatin attenuates ultraviolet induced down-regulation of aquaporin-3 in cultured human skin keratinocytesChao Ji, Yanli Yang, Bo Yang, et al.
Breast Cancer Research and Treatment|June 4, 2024
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancerWenning Shi, Cong Xu, Ping Lei, et al.
Biochemical and Biophysical Research Communications|September 26, 2025
PTPN2 acts as a tumor suppressor and therapeutic target in ovarian cancerXiaoli Sun, Wenkai Zhang, Hongmei Wang, et al.
British Journal of Haematology|March 3, 2024
High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic studyXiaoxiao Chen, Jing Li, Liting Yu, et al.
International Journal of Clinical Pharmacy|August 26, 2025
Development of a machine learning-based risk prediction model and analysis of risk factors for docetaxel-induced bone marrow suppression in breast cancer patientsHongya Ou, Zijan Tan, Anle Shen, et al.
Medical Oncology (Northwood, London, England)|January 4, 2024
Exploring the role of PRDX4 in the development of uterine corpus endometrial carcinomaPing Lei, Liting Yu, Xiaoli Sun, et al.
Pageof 5